πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 64 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11542526

Oncolytic adenoviral vector and methods of use

Unleash Immuno Oncolytics, Inc. Β· Granted Tue Jan 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11246930

Reoviruses having modified sequences

ONCOLYTICS BIOTECH INC. Β· Granted Tue Feb 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10596260

Reoviruses having modified sequences

ONCOLYTICS BIOTECH INC. Β· Granted Tue Mar 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10167452

Viral purification methods

ONCOLYTICS BIOTECH INC. Β· Granted Tue Jan 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10039827

Reoviruses having modified sequences

ONCOLYTICS BIOTECH INC. Β· Granted Tue Aug 07 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 02 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9610352

Lyophilized viral formulations

ONCOLYTICS BIOTECH INC. Β· Granted Tue Apr 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9610309

Liquid viral formulations

ONCOLYTICS BIOTECH INC. Β· Granted Tue Apr 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9365823

Virus clearance of neoplastic cells from mixed cellular compositions

ONCOLYTICS BIOTECH INC. Β· Granted Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9044498

Lyophilized viral formulations

ONCOLYTICS BIOTECH INC. Β· Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9045728

Liquid viral formulations

ONCOLYTICS BIOTECH INC. Β· Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8709443

Reovirus for the treatment of cellular proliferative disorders

ONCOLYTICS BIOTECH INC. Β· Granted Tue Apr 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8691241

Reoviruses having modified sequences

ONCOLYTICS BIOTECH INC. Β· Granted Tue Apr 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8685734

Viral purification methods

ONCOLYTICS BIOTECH INC. Β· Granted Tue Apr 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8658158

Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus

ONCOLYTICS BIOTECH INC. Β· Granted Tue Feb 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8512712

Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions

ONCOLYTICS BIOTECH INC. Β· Granted Tue Aug 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8491886

Viruses for the treatment of cellular proliferative disorders

ONCOLYTICS BIOTECH INC. Β· Granted Tue Jul 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8491884

Virus clearance of neoplastic cells from mixed cellular compositions

ONCOLYTICS BIOTECH INC. Β· Granted Tue Jul 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8470312

Abrogating proinflammatory cytokine production during oncolytic reovirus therapy

ONCOLYTICS BIOTECH INC. Β· Granted Tue Jun 25 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 20 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8147845

Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions

ONCOLYTICS BIOTECH INC. Β· Granted Tue Apr 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8080241

Viruses for the treatment of cellular proliferative disorders

ONCOLYTICS BIOTECH INC. Β· Granted Tue Dec 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8071087

Reovirus for the treatment of cellular proliferative disorders

ONCOLYTICS BIOTECH INC. Β· Granted Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8066985

Reovirus for the treatment of cellular proliferative disorders

ONCOLYTICS BIOTECH INC. Β· Granted Tue Nov 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7964186

Viruses for the treatment of cellular proliferative disorders

ONCOLYTICS BIOTECH INC. Β· Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7964187

Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus

ONCOLYTICS BIOTECH INC. Β· Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted